Obstructive sleep apnea (OSA) is a disorder in which recurrent closure of the upper airways occurs during sleep. Patients habits correction and the treatment of hypothyroidism, if present, may help to resolve this condition, otherwise other treatements may be tried: nasal continuous positive pressure (nCPAP), surgical treatment, or the application of oral appliances. In this paper a case control study with a new type of mandible-advancement device (MAD) (Somnodent ® ) used in OSA treatment is presented.
INTRODUCTION
Obstructive sleep apnea (OSA) is a disorder in which recurrent closure of the upper airways occur during sleep. These frequent arousals are the primary cause of excessive daytime somnolence [1] , associated with impaired daytime cognitive function, and are recognized as a cofactor in the etiology of road traffic accidents. Sleep apnea may also be associated with increased cardiovascular and increased cerebrovascular morbidity and mortality [2, 3] . Many techniques have been used to evaluate the upper airways in patients with obstructive sleep apnea. These techniques have included cephalometry, computed tomography, magnetic resonance imaging, fluoroscopy, acoustic reflection studies and polysomnography (PSG) [4] [5] [6] . Electroencephalogram, eye movements, postural muscle tone, oxygen saturation (SaO 2) , air flow, respiratory effort and heart rate are measured with a complete PSG. Full PSG evaluates the *Address correspondence to this author at the Department of Surgical Sciences, Faculty of Medicine, School of Dentistry, University of Foggia, Viale Pinto, 1, 71100 Foggia, Italy; Tel: +39 0881 588041; Fax: +39 0881 588041; E-mail: llomuzio@tin.it apnea index (AI) and respiratory disturbance index (AHI). AI indicates the number of apneas per hour. AHI indicates the number of apneas/hypopneas per hour of sleeping (this is also called AHI apnea/hypopnea index).
An estimated 82% of men and 92% of women with moderate to severe sleep apnea remain undiagnosed [7] .
OSA treatment is chosen, based on patients clinical features. Its resolution may occurr by losing weight, if the patient is obese, avoid sleeping in the supine position, if the OSA is position dependent, avoid alcohol consumption during the evening and treat hypothyroidism, if present. When these approaches are proved to be unsuccessful, other treatments should be choosen: nasal continuous positive pressure (nCPAP), surgical treatment or the application of oral appliances.
Actually, continuous or bi-level positive airway pressure (CPAP/biPap) represents the gold standard in the treatment of obstructive sleep-related breathing disorders [8] . Many authors suggest that appropriate use of nCPAP in the patients with OSA may be required to decrease implications for cardiovascular morbidity and mortality [9] .
Patients with obstructive sleep apnea and high risk for morbidity may be treated with surgical management with change of upper airways obstruction. Surgical treatment of obstructive sleep apnea is limited to about 15% of the patients and, usually, reserved for those in whom a trial of nasal CPAP fails. In these patients, surgery is the elective form of therapy. Brigance et al. showed how AHI in patients treated with surgical management of OSA significantly improved [10] .
CPAP and surgery treatment reqiure a great patients collaboration. Many authors did not treat severe OSA with mandible-advancement devices (MAD) [11, 12] . In this paper a case control study with a new type of MAD (Somnodent ® ) used in the patients with differing severities of OSA is presented.
MATERIALS AND METHODS
17 patients affected by OSA with a mean age of 53.52 years (range 32 -63) had been evaluated. The absence of temporo-mandibular joint disease and the presence of healthy periodontal ligament were additional inclusion criteria. On each patient head radiographs, with and without oral appliance, were taken in the lateral plane with the head fixed in a cephalostat with a film-focus distance of 4 m and a midsagittal-to-film distance of 0.1 m. Cephalometric assessment of radiographs was performed. The cephalometric protocol measurements and landmarks have been described by Lowe et al. [13, 14] . The maxillary anatomical landmarks were: Anterior Nasal Spine (ANS), maxilla point A (deepest midline point on the maxillary alveolus between ANS and the maxillary alveolar crest), posterior nasal spine (PNS), and the tip of the posterior spine of the palatine bone in the hard palate. The cranium landmarks were: Nasion (N), the anterior point of the frontonasal suture; Sella (S), the center of the sella turcica. The Mandible landmarks were: Gonion (Go), the most lateral external point at the junction of the horizontal and ascending ramus of the mandible; Menton (Me), the lowest point on the body outline of the mandible symphysis. The hyoid landmarks were: Hyoidale (H), the most superioranterior point on the hyoid bone. On the lateral radiograph anterior pharynx space (PAS), Hyoid-Mandible plane distance (MP-H) and ANB were measured. PAS (mm) is the distance between the posterior pharyngeal wall and the dorsal surface of the base of the tongue, measured on the line that intersects GO and B point. The distance between H to Mandible Plane (the joining Me and Go) was measured too. To determine the skeletal class, the ANB-angle was individualized.
Body mass index (BMI) was calculated, mean oxygen saturation (SaO 2 ) and the respiratory disturbance index AHI were evaluated. Each patient received a complete overnight polysomnography (PSG). All subjects were evaluated for one night in a Sleep Laboratory using a portable device, the Embletta system (Flaga, Reykjavik, Iceland). Recording was performed after one night of adaptation to the hospital setting. Airflow was monitored by a nasal cannula and by oral thermistore. The thoracic-abdominal movements of all subjects were detected through two piezoelectric belts.
Overnight continuous recordings of oxygen saturation were obtained by finger pulse oximetry. Snoring was recorded by a microphone placed at the neck, and note was taken of ECG findings and sleep position. Apnea was defined as the cessation of airflow lasting 10 sec; and hypopnea was defined as a discrete reduction (two thirds) of airflow and/or abdominal rib-cage movements lasting 10 sec associated with a > 3% decrease in oxygen saturation. The number of events per hour was obtained by dividing the total number of events by the total sleep time (TST) and was defined as the apnea/hypopnea index (AHI). Also the oxygen desaturation index (ODI) was measured, as the number of arterial oxyhemoglobin saturation dips >=3%. Nocturnal hypoxemia was evaluated in terms of percentage of total sleep time with oxyhemoglobin saturation <90%. Sleep apnea was defined using AHI >=10 per hour. On each patient the test was repeated with oral appliance three months later.
For each patient dental impressions and an interocclusal wax in protrusive comfortable mandible position were used to fabricate the MAD (Fig. 1) . Mean mandible advancement was 4,73 mm (range, 1,5 to 10 mm). The design of this type of MAD was in two acrylic splints. The mandible splint had two buccal flanges angled at 70°, which fitted against buccal blocks on the upper splint to prevent the posterior movement of the mandible. For its retention, tooth undercuts and Adams hooks were used. Flanges length was regulated on each patient to obtain a comfortable wearing. 21 .67 mm (range 10 to 30 mm) and mean PAS was 6.85 mm (range 4 to 9 mm). With the above mentioned mandible advancement, we have very relevant results and improvement as regards AHI and oxygen saturation, whose data with and without MAD application are detailed in Table 1 . MAD application caused a very significant AHI reduction; in fact, mean AHI without MAD was 31.659, while it was reduced to 8.735 with MAD application (P<0.0001).
RESULTS

Mean MP-H was
The reduction of apnea/hypopnea index induced significant variation of oxygen saturation (SaO 2 ) as showed by measurements made during polysomnography test (86.859% vs 93.906%, without and with MAD, respectively: p < 0.0001).
DISCUSSION
OSA is recognized to be a very common clinical condition that affects an estimated 4-5% of middle aged man and 1-2% of middle aged woman [15] .
The definitions of apnea, hypopnea, sleep disordered breathing, and/or OSA are discussed in detail in many researches [16] [17] [18] .
Pathogenesis of OSA is still unclear. Clinically two forms of OSA are decrypted: the primary and the secondary form (Fig. 2 ). An alteration of the central nervous system is present in the primary form (central form) in which alteration of ventilation is related to an incoming of the nervous stimulus at the respiratory system. This type of OSA has a more complex diagnosis and is more difficult to treat than the secondary form.
Reduction of upper airways width, obesity [16] , obstructive factors such as adenoide-tonsillae hypertrophy, PAS reduction, redundant soft palate and prominent base of tongue were included in the secondary form classification [17] .
Airways collapse may occur at the level of the soft palate, at the base of the tongue against the posterior wall of the pharynx, or at both locations [19] .
Typically, after at least 10 seconds without adequate ventilation the patient wakens briefly, inhales, and then returns to sleep. This cycle repeats itself throughout the night, in some cases occurring hundreds of times. Arousals may be due to apnea (complete cessation of breathing for more than 10 seconds), hypopnea (a 50% reduction in thoracoabdominal movement accompanied by a decrease of 4% or more in oxygen saturation), or both. Oxygen levels can be depressed to alarming levels when apneas continue for long periods [20] [21] [22] .
In recent years, great interest received the MAD. In fact, the anterior mandible repositioning causes complex changes within the lateral pharyngeal walls, tongue, soft palate, epiglottis and genioglossus muscle that induce an improvement of respiratory dynamics [23] .
MAD effects in cranium lateral radiography has been evaluated. The PAS increase indicated the intentional effect of MAD (Fig. 3) . This type of therapy is better for a direct low cost to patients and health maintenance organizations.
The properties of the oral appliance has been showed by Ekchart [24] , who reviewed the state of the art of oral appliances and laid out the properties of the devices to be considered, ranging from their reliability at stopping, to the permitted degree of freedom in lateral movements.
To reduce the complications that are commonly associated with MAD, it is very important to establish correct criteria for patients selection. The literature suggests two types of complications: minor (i.e. tooth pain, excess salivation, dry mouth, TMJ discomfort and muscle pain) and severe complications (i.e. TMJ dysfunction, gagging, tooth movement, and intractable muscle pain). MAD [25] may not be used regularly due to complications.
The American sleep disorders association suggest to use MAD only in the patients with no severe OSAs and whenever CPAP failed or it is refused by patients [25] .
A great and significant (P <0.0001) AHI reduction by using MAD has been showed in the present study. This had a beneficial effect also in mean oxygen saturation measured by a complex poliysomnogram; in fact, during sleep with MAD SaO 2 was 93.906% vs 86.859% without MAD, and the difference was statistically significant. The SaO 2 increase may have important implications in the possible reduction of high blood pressure related to secondary policitemy.
CONCLUSIONS
A new OSA therapy with MAD may enhance patients compliance.
The use of MAD in OSAs seems very effective, Thus, capable to reduce complications associated to this condition. In addition, while CPAP is actually the gold standard therapy for OSA, due to its complexity patients are often reluctant to use it; conversely, MAD has the advantage to be comfortable and very easy to use, thus, very good patients compliance can be obtained quite simply. For these reasons MAD seems very promising and worth of further research in OSA therapy.
